erasmusmc.nl Background Preventable diagnostic errors are a large burden on healthcare. Cognitive reasoning tools, that is, tools that aim to improve clinical reasoning, are commonly suggested ...

The win ratio is a method for analyzing a hierarchical composite outcome. It has been most widely used in randomized clinical trials (RCTs) in cardiovascular disease. We performed a review of ...

I believe that it is relevant to consider whether the nomenclature used to describe the clinical trial phases through which diagnostic radiopharmaceuticals pass has been an impediment to critical ...

Design Parallel-group randomised trial (1.1 allocation; intention-to-treat) with nested diagnostic and cost evaluations (EudraCT 2009-011602-42). Setting Participants from 14 London hospitals, imaged ...

Singapore to trial AI system for faster heart disease diagnosis in public hospitals, Illustrative photo (Photo: straitstimes.com) Hanoi – The National Heart Centre Singapore (NHCS) on May 20 announced ...

Primary aldosteronism (PA) is the most common form of secondary hypertension (HTN), with an estimated prevalence of 4% of hypertensive patients in primary care and around 10% of referred patients.

This 2‐center study validates the diagnostic performance of fractional flow reserve (FFR) HARVEY as compared with FFR INVASIVE and demonstrates high accuracy in continuous (percentage of discrepancy, ...

In controlled settings, the AI has demonstrated an accuracy range of 85% to 99%. The upcoming year-long trial will assess how well the system performs in real-world clinical environments.

Yet diagnostic criteria for asthma include bronchodilator response, Sweeney continued. Clinical trials for asthma medications generally require bronchodilator response as part of their enrollment ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate ...